Robert J Bertolini - Net Worth and Insider Trading
Robert J Bertolini Net Worth
The estimated net worth of Robert J Bertolini is at least $7 Million dollars as of 2024-05-05. Robert J Bertolini is the Director of Charles River Laboratories International Inc and owns about 29,134 shares of Charles River Laboratories International Inc (CRL) stock worth over $7 Million. Robert J Bertolini is also the Director of Bristol-Myers Squibb Co and owns about 11,397 shares of Bristol-Myers Squibb Co (BMY) stock worth over $501,354. Details can be seen in Robert J Bertolini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert J Bertolini has not made any transactions after 2020-05-20 and currently still holds the listed stock(s).
Transaction Summary of Robert J Bertolini
Robert J Bertolini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert J Bertolini owns 4 companies in total, including Bristol-Myers Squibb Co (BMY) , Charles River Laboratories International Inc (CRL) , and Merck & Co Inc (MRK) among others .
Click here to see the complete history of Robert J Bertolini’s form 4 insider trades.
Insider Ownership Summary of Robert J Bertolini
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2019-07-31 | director |
| CRL | Charles River Laboratories International Inc | 2020-05-20 | director |
| MRK | Merck & Co Inc | 2003-11-17 | Executive Vice President |
 | | 2003-11-17 | Executive Vice President |
Robert J Bertolini Latest Holdings Summary
Robert J Bertolini currently owns a total of 2 stocks. Among these stocks, Robert J Bertolini owns 29,134 shares of Charles River Laboratories International Inc (CRL) as of May 20, 2020, with a value of $7 Million and a weighting of 93.14%. Robert J Bertolini also owns 11,397 shares of Bristol-Myers Squibb Co (BMY) as of July 31, 2019, with a value of $501,354 and a weighting of 6.86%.
Latest Holdings of Robert J Bertolini
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRL | Charles River Laboratories International Inc | 2020-05-20 | 29,134 | 233.47 | 6,801,915 |
| BMY | Bristol-Myers Squibb Co | 2019-07-31 | 11,397 | 43.99 | 501,354 |
Holding Weightings of Robert J Bertolini
Robert J Bertolini Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert J Bertolini has made a total of 2 transactions in Charles River Laboratories International Inc (CRL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Charles River Laboratories International Inc is the sale of 3,530 shares on May 20, 2020, which brought Robert J Bertolini around $616,267.
According to the SEC Form 4 filings, Robert J Bertolini has made a total of 1 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bristol-Myers Squibb Co is the acquisition of 11,000 shares on July 31, 2019, which cost Robert J Bertolini around $491,920.
Insider Trading History of Robert J Bertolini
- 1
Robert J Bertolini Trading Performance
GuruFocus tracks the stock performance after each of Robert J Bertolini's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert J Bertolini is 29.18%. GuruFocus also compares Robert J Bertolini's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert J Bertolini within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert J Bertolini's insider trading performs compared to the benchmark.
Performance of Robert J Bertolini
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.24 | | | | | |
| Relative Return to S&P 500(%) | 10.05 | | | | | |
Robert J Bertolini Ownership Network
Robert J Bertolini Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Robert J Bertolini is the director of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Robert J Bertolini made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 45,419 shares made by Ann Powell Judge , a net sale of 96,295 shares made by Rupert Vessey , and a net purchase of 5,071 shares made by Christopher S. Boerner .
In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 382,446 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 368,875 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Robert J Bertolini Mailing Address
Above is the net worth, insider trading, and ownership report for Robert J Bertolini. You might contact Robert J Bertolini via mailing address: C/o Schering Plough Corp, 2000 Galloping Hill Rd, Kenilworth Nj 070333.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
